Covaxin
2020 JUN 30
Preliminary >
Science and Technology > Biotechnology > Pharmaceutical sector
IN NEWS:
- A vaccine named Covaxin has become the first to get nod for clinical trials for Covid-19 in India.
About Covaxin:
- It has been developed by Hyderabad based Bharat Biotech.
- It has won the approvals from Drug Controller General of India (DGCI) to start phase I and II clinical trials.
- This is the first such company which has received a go-ahead to start the clinical trials.
- The vaccine has been produced by Bharat Biotech in collaboration with Indian Council of Medical Research (ICMR) and National Institue of Virology (NIV) by using an inactive version of the vaccine.
PRELIMS QUESTION:
Q. Consider the following statements about Covaxin, recently in news:
1.It was developed by an Indian company.
2.Indian Council of Medical Research (ICMR) has cooperated in the development of vaccine.
Which of the statements given above is/are correct:
- 1 only
- 2 only
- Both 1 and 2
- Neither 1 nor 2
Answer to Prelims question